Epitope focusing by variable effective antigen surface concentration
AssigneeDistributed Bio, Inc.
InventorJacob E. GLANVILLE
Life of this patent
Estimating the term…
Loading patent…
AssigneeDistributed Bio, Inc.
InventorJacob E. GLANVILLE
Estimating the term…
The present disclosure provides compositions and methods for the generation of an antibody or immunogenic composition, such as a vaccine, through epitope focusing by variable effective antigen surface concentration. Generally, the composition and methods of the disclosure comprise three steps: a “design process” comprising one or more in silico bioinformatics steps to select and generate a library of potential antigens for use in the immunogenic composition; a “formulation process”, comprising in vitro testing of potential antigens, using various biochemical assays, and further combining two or more antigens to generate one or more immunogenic compositions; and an “administering” step, whereby the immunogenic composition is administered to a host animal, immune cell, subject or patient. Further steps may also be included, such as the isolation and production of antibodies raised by host immune response to the immunogenic composition.
(canceled)
A computing device comprising a processor;
Dependencies are inferred from the claim text.